
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
Author(s) -
Ahmed Alzamzamy,
Hany M. ElSayed,
Mona Abd El-Raouf,
Hanan Eltoukhy,
Tarek Megahed,
Ashraf Aboubakr
Publication year - 2021
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v13.i6.600
Subject(s) - medicine , hepatocellular carcinoma , vascular endothelial growth factor , hepatitis c virus , carcinoma , virus , pathology , gastroenterology , virology , vegf receptors
Hepatocellular carcinoma (HCC) accounts for 8.2% of all cancer-related deaths worldwide. Being a vascular tumor, vascular endothelial growth factor (VEGF) plays a vital role in HCC pathogenesis, growth, and spread.